Evolus, Inc. (EOLS) Cash Flow Statement
Where EOLS’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- −$42.3M
- Capital expenditures
- $8.5M 2.8% of revenue
- Free cash flow
- −$50.7M −17.1% margin
- Returned to shareholders
- —
- Change in cash
- −$33.1M cash at year-end $53.8M
Cash from operations
−$42.3M
Capital expenditures
−$8.5M
Net borrowing (repayment)
+$25.0M
Other financing
−$7.6M
Currency & other
+$254,000
Change in cash
−$33.1M
Drawn to scale: where the cash came from and how it was used. Hover for values.
EOLS operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
EOLS cash flow trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$13.3M2016 | −$42.3M2025 | — | |
| Capital expenditures | $9,0002016 | $8.5M2025 | +113.9%/yr | |
| Free cash flow | −$13.3M2016 | −$50.7M2025 | — | |
| Free cash flow margin | −280.5%2019 | −17.1%2025 | +263.4 pts | |
| Stock-based compensation | $957,0002016 | $20.7M2025 | +40.7%/yr | |
| Share buybacks (net) | $1.3M2016 | $02021 | −100.0% | |
| Capex / revenue | 13.1%2019 | 2.8%2025 | −10.2 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
EOLS cash flow by activity
OperatingInvestingFinancingChange in cash
EOLS net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
EOLS cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$51.6M | −$50.4M | −$61.7M | −$74.4M | −$46.8M | −$163.0M | −$90.0M | −$46.9M | −$4.5M | −$20.1M |
| Depreciation & amortization | $8.7M | $6.0M | $5.9M | $4.5M | $6.3M | $7.7M | $5.0M | $9,000 | $218,000 | $326,000 |
| Stock-based compensation | $20.7M | $22.3M | $16.5M | $10.8M | $9.6M | $10.6M | $9.5M | $7.0M | $586,000 | $957,000 |
| Change in working capital | −$22.5M | −$6.6M | −$5.9M | −$34.3M | −$11.5M | $35.6M | −$20.8M | $2.8M | −$2.1M | $5.4M |
| Other non-cash items | $2.4M | $10.8M | $11.2M | $8.4M | $9.1M | $51.3M | $2.9M | $11.4M | −$7.3M | $93,000 |
| Cash from operating activities | −$42.3M | −$18.0M | −$34.0M | −$84.9M | −$33.4M | −$57.9M | −$93.4M | −$25.7M | −$13.0M | −$13.3M |
| Investing activities | ||||||||||
| Capital expenditures | −$8.5M | −$1.5M | −$1.6M | −$2.9M | −$970,000 | −$3.1M | −$4.6M | −$9,000 | −$9,000 | −$9,000 |
| Investments (net) | — | −$4.8M | −$1.6M | −$2.9M | $5.0M | $12.2M | −$18.9M | −$9,000 | −$18.9M | −$18.9M |
| Acquisitions & other investing | $0 | $1.5M | $1.6M | $2.9M | $0 | $3.1M | $0 | $9,000 | $18.9M | $18.9M |
| Cash from investing activities | −$8.5M | −$4.8M | −$1.6M | −$2.9M | $4.0M | $12.2M | −$23.4M | −$9,000 | −$9,000 | −$9,000 |
| Financing activities | ||||||||||
| Share repurchases & issuance (net) | — | — | — | — | $103.1M | — | $73.1M | −$239,000 | −$1.3M | −$1.3M |
| Net borrowing (repayment) | $25.0M | $0 | $50.0M | −$500,000 | −$27.6M | $39.5M | $70.7M | −$3.9M | $14.3M | $13.3M |
| Shares issued | $0 | $51.2M | $0 | $0 | $103.3M | $94.4M | $73.3M | $124.0M | $0 | $0 |
| Other financing | −$7.6M | −$3.8M | −$5.4M | −$3.6M | −$105.8M | −$95.5M | −$83.5M | −$1.1M | $0 | $1.3M |
| Cash from financing activities | $17.3M | $47.4M | $44.6M | −$4.1M | $73.1M | $38.3M | $133.5M | $118.8M | $13.0M | $13.3M |
| Summary | ||||||||||
| Net change in cash | −$33.1M | $24.1M | $8.9M | −$92.3M | $43.7M | −$7.3M | $16.7M | $93.2M | −$187,000 | −$187,000 |
| Cash at end of period | $53.8M | $87.0M | $62.8M | $53.9M | $146.3M | $102.6M | $109.9M | $93.2M | $187,000 | $187,000 |
| Free cash flow | −$50.7M | −$19.5M | −$35.6M | −$87.9M | −$34.4M | −$61.0M | −$98.0M | −$25.7M | −$13.0M | −$13.3M |
| Free cash flow margin | −17.1% | −7.3% | −17.6% | −59.1% | −34.5% | −107.9% | −280.5% | — | — | — |
| Capex / revenue | 2.8% | 0.6% | 0.8% | 2.0% | 1.0% | 5.6% | 13.1% | — | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$8.1M | −$10.7M | $130,000 | −$15.7M | −$17.1M | −$18.9M | −$6.8M | −$19.2M | −$11.3M | −$13.1M | −$11.8M | −$16.9M |
| Depreciation & amortization | $2.7M | $2.7M | $2.6M | $2.3M | $2.0M | $1.8M | $1.6M | $1.3M | $1.6M | $1.6M | $1.5M | $1.5M |
| Stock-based compensation | $5.6M | $5.1M | $5.1M | $5.1M | $4.5M | $5.9M | $6.2M | $5.2M | $5.8M | $5.1M | $4.4M | $4.6M |
| Change in working capital | −$5.6M | −$8.0M | $6.3M | −$9.0M | −$11.6M | −$8.1M | $1.2M | $3.4M | −$5.0M | −$6.2M | $2.8M | $6.8M |
| Other non-cash items | $1.8M | $894,000 | −$1.4M | $2.7M | −$2.5M | $3.6M | $2.6M | $3.6M | $2.5M | $2.0M | $3.9M | $3.1M |
| Cash from operating activities | −$3.6M | −$10.0M | $12.8M | −$14.7M | −$24.8M | −$15.6M | $4.8M | −$5.7M | −$6.5M | −$10.6M | $813,000 | −$924,000 |
| Investing activities | ||||||||||||
| Capital expenditures | −$1.2M | −$1.7M | −$2.2M | −$2.2M | −$2.3M | −$1.9M | −$1.4M | −$1.4M | −$1.3M | −$797,000 | −$361,000 | −$539,000 |
| Investments (net) | — | — | — | −$2.2M | −$2.3M | −$1.9M | −$1.4M | −$1.4M | −$1.3M | −$797,000 | −$361,000 | −$1.3M |
| Acquisitions & other investing | $726,000 | $0 | $0 | $2.2M | $2.3M | $1.9M | $1.4M | $1.4M | $1.3M | $797,000 | $361,000 | $1.3M |
| Cash from investing activities | −$500,000 | −$1.7M | −$2.2M | −$2.2M | −$2.3M | −$1.9M | −$1.4M | −$1.4M | −$1.3M | −$797,000 | −$361,000 | −$539,000 |
| Financing activities | ||||||||||||
| Net borrowing (repayment) | −$4,000 | $10.0M | −$4,000 | −$4,000 | $25.0M | $0 | $0 | $0 | — | — | — | — |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.2M | $47.0M | $0 | $0 |
| Other financing | −$361,000 | −$2.4M | $81,000 | −$1.8M | −$4.3M | −$1.6M | −$1.3M | −$1.4M | $274,000 | −$1.3M | $23.5M | −$1.4M |
| Cash from financing activities | −$365,000 | $7.6M | $77,000 | −$1.8M | $20.7M | −$1.6M | −$1.3M | −$1.4M | $4.5M | $45.7M | $23.5M | −$1.4M |
| Summary | ||||||||||||
| Net change in cash | −$4.6M | −$4.0M | $10.3M | −$18.2M | −$6.2M | −$19.1M | $1.9M | −$8.6M | −$3.3M | $34.1M | $24.2M | −$3.0M |
| Cash at end of period | $45.2M | $49.8M | $53.8M | $43.5M | $61.7M | $67.9M | $87.0M | $85.0M | $93.7M | $97.0M | $62.8M | $38.7M |
| Free cash flow | −$2.4M | −$11.6M | $10.7M | −$16.8M | −$27.1M | −$17.5M | $3.4M | −$7.1M | −$7.7M | −$11.4M | $452,000 | −$1.5M |
| Free cash flow margin | −2.8% | −15.9% | 11.8% | −24.4% | −39.0% | −25.5% | 4.4% | −11.7% | −11.5% | −19.2% | 0.7% | −2.9% |
| Capex / revenue | 1.5% | 2.3% | 2.4% | 3.1% | 3.3% | 2.7% | 1.7% | 2.3% | 1.9% | 1.3% | 0.6% | 1.1% |
| Operating cash flow / net income | — | — | 98.67 | — | — | — | — | — | — | — | — | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
EOLS cash generation
In fiscal 2025 (ended December 31, 2025), Evolus generated -$42.3 million of cash from operations and spent $8.5 million on capital expenditures, leaving free cash flow of -$50.7 million, −17.1% of revenue. Cash and equivalents fell by $33.1 million over the year.
Related: EOLS income statement, EOLS balance sheet. See the EOLS stock overview for the latest quote and news.
EOLS cash flow FAQ
What is Evolus's free cash flow?
Evolus's free cash flow was -$50.7 million in fiscal 2025: -$42.3 million of operating cash flow minus $8.5 million of capital expenditures It was -$19.5 million a year earlier..
How much cash does Evolus generate from operations?
Evolus generated -$42.3 million of cash from operating activities in fiscal 2025.
How much does Evolus spend on capital expenditures?
Evolus spent $8.5 million on capital expenditures in fiscal 2025, 2.8% of revenue, compared with $1.5 million the year before.